Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT04388137 Not yet recruiting - Clinical trials for Functional Gastrointestinal Disorders

Multi-center Study on Pediatric Functional Gastrointestinal Disorders in Mainland China

Start date: June 1, 2020
Phase:
Study type: Observational

This study plans to understand the prevalence and clinical characteristics of pediatric functional gastrointestinal disorders in mainland China through multi-center investigation and clinical epidemiological analysis, to reveal the prevalence characteristics and related factors of functional gastrointestinal disorders in children of all ages in mainland China, to establish a diagnostic standard system for pediatric functional gastrointestinal disorders in mainland China, to provide evidence-based basis for the formulation of new Roman standard for functional gastrointestinal disorders, and to provide new ideas and treatment basis for the diagnosis and treatment of functional gastrointestinal disorders in children.

NCT ID: NCT04295512 Not yet recruiting - Clinical trials for Autism Spectrum Disorder

Adaptation and Implementation of an ASD Executive Functioning Intervention in Children's Mental Health Services

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this project is to conduct a feasibility test of an ASD executive functioning intervention adapted for mental health settings, including examining the effectiveness and process of implementing this adapted intervention in community mental health programs.

NCT ID: NCT04288609 Not yet recruiting - Affective Disorder Clinical Trials

Effectiveness of a Cognitive Remediation Intervention Based on Virtual Reality for Promotion of Cognitive Functioning and Participation in Daily Life Among Persons With Affective Disorder

Start date: March 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of remedial cognitive intervention using The Functional Brain Trainer VR (FBT, Intendo ©) to improve cognitive functioning, participation in daily life occupations, and functional capacity in the field of IADL among people with affective disorders receiving inpatient and daycare mental-health services.

NCT ID: NCT04280900 Not yet recruiting - Clinical trials for Cocaine-Related Disorders

Benefits of Therapy With Virtual Reality Exposure in the Treatment of Cocaine Use Disorders

CORVI
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Cocaine addiction is a multifactorial disease with important consequences: somatic, psychiatric... The number of applications for treatment for cocaine addiction is gradually increasing from year to year but no conventional treatment is available. New tools such as virtual reality could be used in this treatment. We propose to create a virtual reality program based on the analysis of high-risk relapse situations described by patients. We will then assess the effect of this cybertherapy on patients' relapse time and their desire to use cocaine

NCT ID: NCT04265729 Not yet recruiting - Clinical trials for Complex Conditions, Including Impairment of the GI Tract

Neocate In Infants and Children With Complex Conditions

NICC
Start date: March 2020
Phase: N/A
Study type: Interventional

Infants and young children up to 10 years of age with a complex condition involving the gastrointestinal tract are at risk of poor nutritional status, including faltering growth. Due to the complex condition, standard nutrition is often not tolerated and causes gastrointestinal symptoms. Formulas in which protein is replaced by its smallest elements, amino acids are easier for the body to digest and absorb. These formulas might be tolerated better and reduce gastrointestinal symptoms in infants and young children with complex conditions. The objectives of the present, exploratory study are to gain clinical evidence related to the nutritional status and gastrointestinal tolerance in infants and young children with complex conditions receiving Neocate as their primary source of nutrition. Additional objectives are to describe the nutritional and pharmacological management of these infants and young children. Study duration for each participant will be 52 weeks at maximum.

NCT ID: NCT04253769 Not yet recruiting - Clinical trials for Hematologic Disease and Disorders

NHLBI Research Participant Recruitment Registry

Start date: February 14, 2020
Phase:
Study type: Observational

Background: The National Heart, Lung, and Blood Institute (NHLBI) conducts clinical trials that look at new ways to prevent, detect, or treat disease. It wants to create an NHLBI Recruitment Registry that lets people sign up to be contacted for NHLBI studies. It also wants to make sure that the data people share about themselves is safely stored. Researchers will be able to use this registry to prescreen people for clinical trials. Objective: To create and maintain an NHLBI research participant recruitment registry. This is an observational registry for collecting, storing, and providing access to data on people with a disease or condition of interest, or as a healthy volunteer to the NHLBI. Eligibility: People who contact the NIH to participate in an NHLBI IRB-approved study Design: Researchers will contact participants by telephone to obtain informed consent verbally. Participants will give the following data: - name - date of birth - phone number - address - email address - diagnosis (if applicable) - referring provider. Participants will share how they heard of the study. They may give their medical records. They may be asked if they were enrolled in an NHLBI study in the past. Participants will be asked if they would like to be contacted for other current or future studies. If they say no, they will not be contacted. But their data will stay in the database. They can also withdraw from the registry. If they do, their reason will be recorded in the database. The registry will be created and maintained by the Office of the Clinical Director at NHLBI.

NCT ID: NCT04253600 Not yet recruiting - Clinical trials for Language Development

Understanding the Predictive Factors and the Neurocognitive Basis of Developmental Language Disorder

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

For most children, language acquisition might appear like an effortless phenomenon, mostly arising from informal daily interaction with their surrounding people. Despite an adequate learning environment however, some children encounter major difficulties in learning their native tongue and develop a Developmental Language Disorder (DLD). Although the existence of a multi-factorial etiology has seemed to reach an agreement, presumably combining genetic and environmental factors to some kind of neural disruption, the underlying mechanisms leading to DLD are, to date, poorly understood. Many studies have attempted to identify risk factors and early predictors associated with the future development of a language impairment. However, despite the constant efforts to identify early markers able to differentiate between transient and persistent language difficulties, early detection of children who will be developing a DLD remains highly difficult, partially due to the lack of direct and ecological measures of early language and communication development. In addition research on the causal neural correlates of DLD is in its infancy, and often compromised by small sample sizes or analyses methods that lack anatomical specificity to determine the neural correlates of language impairment. Hence, In order to improve early detection and, therefore, language intervention, this longitudinal research project aims at investigating the early predictive factors as well as the neurocognitive basis of DLD by means of an integrative, multi-dimensional, and multi-methodological approach. To substantially gain insight, this research ideally integrates risk factors at multiple different levels, including the cognitive, neurobiological, parental and environmental level. From a methodological perspective, we will combine direct and indirect behavioral methods with neuroimaging methods in order to propose an early predictive model of language development.

NCT ID: NCT04232800 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Riboflavin for Glutamate Reduction in Alcohol Withdrawal

RGRAW
Start date: December 1, 2021
Phase: Phase 2
Study type: Interventional

This RCT intends to investigate the use of oral Riboflavin (Vitamin B2) for reduction of blood glutamate levels in the setting of acute alcohol withdrawal. Participants will be patients admitted to an inpatient hospital unit diagnosed with acute alcohol withdrawal. In addition to receiving care as usual, they will be randomized to receive either 100mg TID riboflavin or an identically dosed placebo. The primary outcome measure will be blood glutamate levels. Secondary outcomes will include measures of alcohol withdrawal and alcohol craving. The investigators hypothesize that those in the riboflavin group will have lower blood levels of glutamate, as well as decreased symptoms of alcohol withdrawal.

NCT ID: NCT04230811 Not yet recruiting - Clinical trials for Corneal Ulcer (Diagnosis)

Diagnosing Corneal Infection

Start date: February 1, 2025
Phase:
Study type: Observational

Microbial keratitis is a common and serious eye disease in Edinburgh. Prompt treatment with antibiotics can prevent sight loss, and identification of the micro-organism and its antibiotic sensitivities are key to appropriate management. Standard practice of collecting infected material from the cornea using a blade can be distressing and time-consuming. Corneal impression membranes (CIM) have recently been introduced to another National Health Service (NHS) eye unit (St Paul's Eye Unit, Liverpool) as they detect more micro-organisms and are more patient-friendly than corneal scrape. The aim of this study is to compare CIM with reference to current standard practice of corneal scrape. If CIM have greater sensitivity and fewer adverse events than scrape then the investigators will consider using CIM instead of scrape in routine clinical care. The investigators will also collect additional CIM to help develop new microbiological tests being developed at the University of Edinburgh, which if successful could be applied to CIM at the bedside to further improve the speed of diagnosis in the future. Development of the new microbiological tests is facilitated by having samples of germs from eye infections. Study design: cross-sectional study comparing diagnostic techniques Participants: recruited from the Acute referral clinic at the Princess Alexandra Eye Pavilion, or emergency on-call ophthalmology service What is involved: subjects with microbial keratitis will have standard investigations to identify the germ causing the infection. In addition the investigators will capture germs using CIM, and will compare CIM with the standard test to see which is better. Funding: departmental funding

NCT ID: NCT04206969 Not yet recruiting - Clinical trials for Major Depressive Disorder

Assessment of Transcultural Psychotherapy in Child Major Depressive Disorder

EDPT-ADOS
Start date: April 2020
Phase: N/A
Study type: Interventional

The symptomatic and clinical expression of psychiatric disorders in children and adolescents is strongly influenced by the cultural setting they are growing up in. These cultural variations complicate psychiatric care, especially for migrant children, for whom appropriate care must be designed. Transcultural psychotherapy is an original psychotherapeutic technique developed to meet these specific requirements in France and in different European and American countries. Its theoretical and methodological foundations rest on the works of George Devereux in ethnopsychiatry (1970). A psychotherapeutic technique intended for first-generation migrants was developed by Tobie Nathan and coll (1986). Marie-Rose Moro and colleagues (1990) have adapted this technique to second-generation migrants. Indicated as a second-line treatment after the failure of standard management, this technique is fully formalized today. It comprises group consultations for the child and the family as a one-hour session each month, directed by a principal therapist, assisted by a group of co-therapists (of diverse cultural origins and occupations) and an interpreter in the family's mother tongue. The concept of culture is used to establish the therapeutic alliance, decode the symptoms, and propose treatment. The children and adolescents receiving this treatment have varied psychopathological profiles, mostly involving depressive and/or anxiety disorders. Specifically, migrants' children are especially vulnerable to depression, their psychiatric care is generally longer and less effective than in the general population, and their rate of treatment failure higher. Transcultural psychotherapy has demonstrated its value in these situations in numerous qualitative studies, but its efficacy has not yet been assessed by a method providing a high level of evidence, such as randomized controlled trials.